Chinese General Practice ›› 2021, Vol. 24 ›› Issue (36): 4628-4632.DOI: 10.12114/j.issn.1007-9572.2021.02.064
Special Issue: 神经系统疾病最新文章合辑; 老年问题最新文章合辑; 脑健康最新研究合辑
• Monographic Research • Previous Articles Next Articles
Published:
2021-12-20
Online:
2021-12-20
基金资助:
ZHANG Donglin,LI Chengliang,LI Dan,WANG Minjuan. Study on the Level of Parathyroid Hormone and Severity and Prognosis of Cerebral Ischemic Stroke Severity in Middle-aged and Elderly People [J]. Chinese General Practice, 2021, 24(36): 4628-4632.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.064
项目 | 病例组(n=79) | 对照组(n=65) | t(χ2)值 | P值 |
---|---|---|---|---|
年龄(岁) | 67.73±11.33 | 66.08±5.611 | 1.076 | 0.284 |
性别(男/女) | 52/27 | 31/34 | 4.801a | 0.042 |
吸烟〔n(%)〕 | 26(32.9) | 16(24.6) | 1.188a | 0.357 |
饮酒〔n(%)〕 | 7(8.9) | 6(9.2) | 0.006a | 0.582 |
高血压病〔n(%)〕 | 42(53.2) | 22(33.8) | 5.390a | 0.028 |
糖尿病〔n(%)〕 | 13(16.5) | 17(26.2) | 2.034a | 0.216 |
冠心病〔n(%)〕 | 25(31.6) | 19(29.2) | 0.098a | 0.856 |
收缩压(mm Hg) | 143±22 | 130±15 | 4.374 | <0.001 |
舒张压(mm Hg) | 86±13 | 76±8 | 6.201 | <0.001 |
WBC(×109/L) | 6.7±2.4 | 5.9±1.5 | 2.508 | 0.010 |
TC(mmol/L) | 4.21±0.96 | 4.00±0.91 | 1.375 | 0.171 |
TG(mmol/L) | 1.53±1.08 | 1.29±0.41 | 1.815 | 0.072 |
HDL-C(mmol/L) | 1.14±0.27 | 1.14±0.22 | 0.036 | 0.971 |
LDL-C(mmol/L) | 2.53±0.87 | 2.28±0.68 | 1.943 | 0.226 |
空腹血糖(mmol/L) | 6.2±1.9 | 6.5±1.7 | -1.206 | 0.230 |
血尿酸(μmol/L) | 302±96 | 312±92 | -0.594 | 0.552 |
血肌酐(μmol/L) | 71.3±22.6 | 66.6±18.2 | 1.359 | 0.176 |
BMI(kg/m2) | 24.2±3.6 | 23.4±3.1 | 1.245 | 0.217 |
PTH(ng/L) | 12.0±3.7 | 10.4±4.2 | 2.380 | 0.019 |
VD(pmol/L) | 122±29 | 130±21 | -2.005 | 0.047 |
IL-6(ng/L) | 7.1±1.5 | 6.4±0.9 | 3.136 | 0.002 |
Table 1 Comparison of the general data between the two groups
项目 | 病例组(n=79) | 对照组(n=65) | t(χ2)值 | P值 |
---|---|---|---|---|
年龄(岁) | 67.73±11.33 | 66.08±5.611 | 1.076 | 0.284 |
性别(男/女) | 52/27 | 31/34 | 4.801a | 0.042 |
吸烟〔n(%)〕 | 26(32.9) | 16(24.6) | 1.188a | 0.357 |
饮酒〔n(%)〕 | 7(8.9) | 6(9.2) | 0.006a | 0.582 |
高血压病〔n(%)〕 | 42(53.2) | 22(33.8) | 5.390a | 0.028 |
糖尿病〔n(%)〕 | 13(16.5) | 17(26.2) | 2.034a | 0.216 |
冠心病〔n(%)〕 | 25(31.6) | 19(29.2) | 0.098a | 0.856 |
收缩压(mm Hg) | 143±22 | 130±15 | 4.374 | <0.001 |
舒张压(mm Hg) | 86±13 | 76±8 | 6.201 | <0.001 |
WBC(×109/L) | 6.7±2.4 | 5.9±1.5 | 2.508 | 0.010 |
TC(mmol/L) | 4.21±0.96 | 4.00±0.91 | 1.375 | 0.171 |
TG(mmol/L) | 1.53±1.08 | 1.29±0.41 | 1.815 | 0.072 |
HDL-C(mmol/L) | 1.14±0.27 | 1.14±0.22 | 0.036 | 0.971 |
LDL-C(mmol/L) | 2.53±0.87 | 2.28±0.68 | 1.943 | 0.226 |
空腹血糖(mmol/L) | 6.2±1.9 | 6.5±1.7 | -1.206 | 0.230 |
血尿酸(μmol/L) | 302±96 | 312±92 | -0.594 | 0.552 |
血肌酐(μmol/L) | 71.3±22.6 | 66.6±18.2 | 1.359 | 0.176 |
BMI(kg/m2) | 24.2±3.6 | 23.4±3.1 | 1.245 | 0.217 |
PTH(ng/L) | 12.0±3.7 | 10.4±4.2 | 2.380 | 0.019 |
VD(pmol/L) | 122±29 | 130±21 | -2.005 | 0.047 |
IL-6(ng/L) | 7.1±1.5 | 6.4±0.9 | 3.136 | 0.002 |
项目 | 偏回归系数 | 标准误 | OR值 | 95%CI | Wald χ2值 | P值 |
---|---|---|---|---|---|---|
舒张压 | -0.101 | 0.021 | 0.904 | (0.866,0.942) | 22.405 | <0.001 |
PTH | -0.130 | 0.052 | 0.878 | (0.793,0.972) | 6.295 | 0.012 |
IL-6 | -0.558 | 0.202 | 0.566 | (0.381,0.842) | 7.893 | 0.005 |
Table 2 Binary Logistic regression analysis of influencing factors of ischemic stroke in middle-aged and elderly people
项目 | 偏回归系数 | 标准误 | OR值 | 95%CI | Wald χ2值 | P值 |
---|---|---|---|---|---|---|
舒张压 | -0.101 | 0.021 | 0.904 | (0.866,0.942) | 22.405 | <0.001 |
PTH | -0.130 | 0.052 | 0.878 | (0.793,0.972) | 6.295 | 0.012 |
IL-6 | -0.558 | 0.202 | 0.566 | (0.381,0.842) | 7.893 | 0.005 |
分级 | 例数 | PTH | F值 | P值 | |
---|---|---|---|---|---|
脑梗死面积 | 11.163 | <0.001 | |||
小 | 35 | 9.1±1.6 | |||
中 | 33 | 12.0±2.0 | |||
大 | 21 | 15.6±2.0 | |||
神经功能缺损情况 | 0.355 | 0.702 | |||
轻 | 36 | 12.1±3.7 | |||
中 | 34 | 11.7±3.6 | |||
重 | 9 | 12.9±2.0 | |||
神经功能恢复状况 | 6.530 | 0.002 | |||
好 | 35 | 10.4±3.0 | |||
中 | 27 | 13.6±3.8 | |||
差 | 17 | 12.7±1.0 |
Table 3 Comparison of PTH in patients with acute ischemic stroke with different cerebral infarction area,neurological deficit and neurological recovery
分级 | 例数 | PTH | F值 | P值 | |
---|---|---|---|---|---|
脑梗死面积 | 11.163 | <0.001 | |||
小 | 35 | 9.1±1.6 | |||
中 | 33 | 12.0±2.0 | |||
大 | 21 | 15.6±2.0 | |||
神经功能缺损情况 | 0.355 | 0.702 | |||
轻 | 36 | 12.1±3.7 | |||
中 | 34 | 11.7±3.6 | |||
重 | 9 | 12.9±2.0 | |||
神经功能恢复状况 | 6.530 | 0.002 | |||
好 | 35 | 10.4±3.0 | |||
中 | 27 | 13.6±3.8 | |||
差 | 17 | 12.7±1.0 |
[1] | O'NEILL D. Global burden of stroke:an underestimate[J]. Lancet,2014,383(9924):1205. DOI:10.1016/S0140-6736(14)60595-X. |
[2] | DELLA-MORTE D, GUADAGNI F, PALMIROTTA R,et al. Genetics of ischemic stroke,stroke-related risk factors,stroke precursors and treatments[J]. Pharmacogenomics,2012,13(5):595-613. DOI:10.2217/pgs.12.14. |
[3] | SCHILLACI G, PUCCI G, PIRRO M,et al. Large-artery stiffness:a reversible marker of cardiovascular risk in primary hyperparathyroidism[J]. Atherosclerosis,2011,218(1):96-101. DOI:10.1016/j.atherosclerosis.2011.05.010. |
[4] | GOETTSCH C, IWATA H, AIKAWA E. Parathyroid hormone:critical bridge between bone metabolism and cardiovascular disease[J]. Arterioscler Thromb Vasc Biol,2014,34(7):1333-1335. DOI:10.1161/ATVBAHA.114.303637. |
[5] | WANNAMETHEE S G, WELSH P, PAPACOSTA O,et al. Elevated parathyroid hormone,but not vitamin D deficiency,is associated with increased risk of heart failure in older men with and without cardiovascular disease[J]. Circ Heart Fail,2014,7(5):732-739. DOI:10.1161/CIRCHEARTFAILURE.114.001272. |
[6] | LISHMANOV A, DORAIRAJAN S, PAK Y,et al. Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease[J]. Int Urol Nephrol,2012,44(2):541-547. DOI:10.1007/s11255-010-9897-2. |
[7] | 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志,2015,48(4):246-257. DOI:10.3760/cma.j.issn.1006-7876.2015.04.002. |
[8] | BOSWORTH C, SACHS M C, DUPREZ D,et al. Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis[J]. Clin Endocrinol (Oxf),2013,79(3):429-436. DOI:10.1111/cen.12163. |
[9] | STRUCK J, MORGENTHALER N G, BERGMANN A. Copeptin,a stable peptide derived from the vasopressin precursor,is elevated in serum of Sepsis patients[J]. Peptides,2005,26(12):2500-2504. DOI:10.1016/j.peptides.2005.04.019. |
[10] | ÇELIK G, DOGAN A, DENER S,et al. Parathyroid hormone levels in the prediction of ischemic stroke risk[J]. Dis Markers,2017,2017:4343171. DOI:10.1155/2017/4343171. |
[11] | SUN Q, PAN A, HU F B,et al. 25-Hydroxyvitamin D levels and the risk of stroke:a prospective study and meta-analysis[J]. Stroke,2012,43(6):1470-1477. DOI:10.1161/STROKEAHA.111.636910. |
[12] | ZHANG Y F, JIANG L, YANG P,et al. Comparison of lymphocyte count,neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting the severity and the clinical outcomes of acute cerebral infarction patients[J]. Clin Lab,2019,65(7):102-106. DOI:10.7754/Clin.Lab.2019.190102. |
[13] | VILA N, CASTILLO J, DÁVALOS A,et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke[J]. Stroke,2000,31(10):2325-2329. DOI:10.1161/01.str.31.10.2325. |
[14] | ACALOVSCHI D, WIEST T, HARTMANN M,et al. Multiple levels of regulation of the interleukin-6 system in stroke[J]. Stroke,2003,34(8):1864-1869. DOI:10.1161/01.STR.0000079815.38626.44. |
[15] | DAUBAIL B, JACQUIN A, GUILLAND J C,et al. Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients[J]. Eur J Neurol,2013,20(1):57-61. DOI:10.1111/j.1468-1331.2012.03758.x. |
[16] | PARK K Y, CHUNG P W, KIM Y B,et al. Serum vitamin D status as a predictor of prognosis in patients with acute ischemic stroke[J]. Cerebrovasc Dis,2015,40(1/2):73-80. DOI:10.1159/000434691. |
[17] | 王楠,张双,刘永政,等. 曲美他嗪联合运动康复对慢性心力衰竭患者心肾功能及甲状旁腺素的影响[J]. 实用心脑肺血管病杂志,2018,26(3):104-108. DOI:10.3969/j.issn.1008-5971.2018.03.030. |
[18] | HELDNER M R, ZUBLER C, MATTLE H P,et al. National Institutes of Health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke[J]. Stroke,2013,44(4):1153-1157. DOI:10.1161/STROKEAHA.111.000604. |
[1] | XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822. |
[2] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[3] | XU Yanpeng, HUANG Pe, ZHANG Pingping, LUO Yan, SHI Xiaoqi, WU Liusong, CHEN Yan, HE Zhixu. Expression of β-Adrenergic Receptors in Acute T-cell Lymphoblastic Leukemia and Its Clinical Significance [J]. Chinese General Practice, 2025, 28(27): 3391-3398. |
[4] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[5] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[6] | CHOU Xintong, PENG Hanyu, MA Hui, ZHANG Zhen, SU Xian, QIU Hongyan. Maternal Preferences in Contraceptive Decision-making: an Analysis of Influencing Factors [J]. Chinese General Practice, 2025, 28(26): 3294-3299. |
[7] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[8] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[9] | YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina. Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(24): 3000-3004. |
[10] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[11] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
[12] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[13] | WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914. |
[14] | DING Zijun, ZHOU Nannan, LUO Xing, LUO Jieyu, HAO Wenjuan, ZHANG Chunjiang, JIN Xin, ZHAO Dan. Cognitive Impairment in Patients on Maintenance Hemodialysis and Its Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2025, 28(23): 2885-2893. |
[15] | CHEN Fei, WANG Jinying, YU Haibo, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, ZHANG Tianyu, HUANG Zhongxia. Significance of Elevated Urinary NGAL, TIM-1, VCAM-1 and Activin A in Patients with New Diagnosed Multiple Myeloma [J]. Chinese General Practice, 2025, 28(22): 2740-2749. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||